GLP1-derived nonapeptide GLP1(28-36)amide protects pancreatic β-cells from glucolipotoxicity
about
Regulation of glucose homeostasis by GLP-1Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTORFoxO Transcription Factors and Regenerative Pathways in Diabetes MellitusNew insight into the mechanisms underlying the function of the incretin hormone glucagon-like peptide-1 in pancreatic β-cells: the involvement of the Wnt signaling pathway effector β-cateninErythropoietin: new directions for the nervous systemTargeting disease through novel pathways of apoptosis and autophagyLipotoxicity in the pancreatic beta cell: not just survival and function, but proliferation as well?Nanoparticle ligand presentation for targeting solid tumorsErythropoietin and mTOR: A "One-Two Punch" for Aging-Related Disorders Accompanied by Enhanced Life ExpectancyNew Insights for Oxidative Stress and Diabetes MellitusNovel applications of trophic factors, Wnt and WISP for neuronal repair and regeneration in metabolic diseaseGLP-1(28-36)amide, the Glucagon-like peptide-1 metabolite: friend, foe, or pharmacological folly?New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders.GLP-1(32-36)amide Pentapeptide Increases Basal Energy Expenditure and Inhibits Weight Gain in Obese MiceEndogenous GLP-1 as a key self-defense molecule against lipotoxicity in pancreatic isletsThe role of the Wnt signaling pathway in incretin hormone production and function.Oxidant stress and signal transduction in the nervous system with the PI 3-K, Akt, and mTOR cascadeNovel directions for diabetes mellitus drug discoveryGLP-1(32-36)amide, a novel pentapeptide cleavage product of GLP-1, modulates whole body glucose metabolism in dogsIncretins: their physiology and application in the treatment of diabetes mellitus.Programming apoptosis and autophagy with novel approaches for diabetes mellitus.Novel Pentapeptide GLP-1 (32-36) Amide Inhibits β-Cell Apoptosis In Vitro and Improves Glucose Disposal in Streptozotocin-Induced Diabetic Mice.Hepatic functions of GLP-1 and its based drugs: current disputes and perspectives.Fibroblast growth factor 21 and its novel association with oxidative stress.GLP-1 receptor independent pathways: emerging beneficial effects of GLP-1 breakdown products.GLP-1(28-36) improves β-cell mass and glucose disposal in streptozotocin-induced diabetic mice and activates cAMP/PKA/β-catenin signaling in β-cells in vitro.Anti-diabetic Effects of Clostridium butyricum CGMCC0313.1 through Promoting the Growth of Gut Butyrate-producing Bacteria in Type 2 Diabetic Mice.Allantoin ameliorates chemically-induced pancreatic β-cell damage through activation of the imidazoline I3 receptorsmTOR: Driving apoptosis and autophagy for neurocardiac complications of diabetes mellitus.The bright side of reactive oxygen species: lifespan extension without cellular demise.GLP-1(28-36)amide, a Long Ignored Peptide Revisited.GLP-1-derived nonapeptide GLP-1(28-36)amide represses hepatic gluconeogenic gene expression and improves pyruvate tolerance in high-fat diet-fed mice.Energy depletion and not ROS formation is a crucial step of glucolipotoxicity (GLTx) in pancreatic beta cells.Fatty Acids, Antioxidants and Physical Activity in Brain Aging.Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1
P2860
Q24563430-0990B7C8-892F-4E4A-AF21-2DA3D34D101DQ26749047-0838828B-1148-4216-81C5-51625AB8C836Q26800615-F7D91BB7-26BD-4505-8EDF-3CDF0704D2DBQ26823824-8CA421E1-15F9-4E0E-9A5D-33B206B2ABF8Q26828425-8B7D21FE-C3FE-41EC-B4DB-EA3A6F636604Q26864639-1F2CF239-4D80-4E11-866D-16CBC4BDB541Q26866054-E5F4D6E9-F09A-45F3-B65B-9689EE596733Q27009522-C9C09DB9-D170-4C3E-B679-4E3D06B7A168Q28066377-4F607B31-5749-43B0-8775-02252F19BBE3Q28080679-6DC49173-A076-4298-842F-7EF7B7DDD3FBQ28085715-EFD68A7A-A1C9-42F9-8AF2-8829DC355AC4Q33734024-CD2F6B6D-9EAE-4B59-93A9-EA6B455E51AEQ33783000-5573CB04-444E-49DB-A482-F9509C799D05Q35769544-A9FF9AB1-CD06-455A-A67F-1E55C2328532Q35827634-105C13EE-1D19-40C5-BFB2-CDA99942E59BQ36193707-DD44A871-27EE-45D3-80F8-C4C7E072F732Q36432388-CDEEA6F4-7474-4902-B393-B9F3250D6CE2Q36487424-555259F7-A632-433E-ACDC-95CCC81AA35FQ37501537-4C10AA4E-B9F9-4C4E-9890-32D3782CC0C8Q38225693-B0B347B3-7A02-4EA5-9EEB-9A8CD219A525Q38367977-EAFB69DA-5781-49E9-A6CD-B0D34D3D8EA0Q38852616-48868CE6-B2DC-4A18-90B9-730E20962C32Q38923365-156348D3-C89D-4B89-AC4C-497012E22FA5Q39063540-64C13776-36CD-4D67-B017-3DF1EED15874Q39063954-823584E3-6FBC-4238-8011-9D723CAE0285Q39168828-27987A2F-977E-47C3-8921-88A402C96694Q41203575-93BF169A-D25E-4DAE-A72B-4010C2F53AAFQ41980480-EBEDA07F-710A-479F-A7C6-A0C6FD958576Q42031136-5C55977C-B9E7-4012-B561-C8783711EB8AQ42782106-616FBFBF-3384-4C9E-BBD1-2A75597A022FQ43105364-3F0575A3-D645-4339-93BF-36DE4C63D15EQ43636905-959F1149-50FD-469A-826F-E77DFCDEC98CQ46245542-932482B5-05B5-495E-A4DF-F1EEEF08E8E1Q47156198-4B23A9C5-D4BF-4096-A280-F5538DC70C0EQ58572799-57A05C3F-6C4C-4005-B7D4-CF064157BEA1
P2860
GLP1-derived nonapeptide GLP1(28-36)amide protects pancreatic β-cells from glucolipotoxicity
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
GLP1-derived nonapeptide GLP1( ...... β-cells from glucolipotoxicity
@ast
GLP1-derived nonapeptide GLP1( ...... β-cells from glucolipotoxicity
@en
type
label
GLP1-derived nonapeptide GLP1( ...... β-cells from glucolipotoxicity
@ast
GLP1-derived nonapeptide GLP1( ...... β-cells from glucolipotoxicity
@en
prefLabel
GLP1-derived nonapeptide GLP1( ...... β-cells from glucolipotoxicity
@ast
GLP1-derived nonapeptide GLP1( ...... β-cells from glucolipotoxicity
@en
P2093
P2860
P356
P1476
GLP1-derived nonapeptide GLP1( ...... β-cells from glucolipotoxicity
@en
P2093
Joel F Habener
Luke J Brindamour
Violeta Stanojevic
Zhengu Liu
P2860
P304
P356
10.1530/JOE-11-0328
P407
P577
2012-03-13T00:00:00Z